$MRNA is a haven for LOs. They have to keep buying to not fall behind the benchmark. RCC data coming up.
View original →Cite asCryptoQuant has tracked the directional calls on BIIB by @JPZaragoza1 on X since Sep 2017: not yet scored on BIIB (as of Nov 11, 2026).
2 BIIB calls on record, a thin history.
Relative view by default: fewer than 30 BIIB calls or days on record.
Sentiment timeline shows relative sentiment within this analyst's history. A perma-bull showing 8 bullish : 2 bearish in a bear market sets that as their baseline. If you notice any errors, claim @JPZaragoza1 to submit corrections.
Hover the chart to read the thesis of that period · click a day to pin it
$MRNA is a haven for LOs. They have to keep buying to not fall behind the benchmark. RCC data coming up.
View original →Good to see $COAG holding on this tape. I think we can get some additional good data from 002 in VWD, potentially at #ASH26 and then sutacimig data in FVII in Q1
View original →$CNTB what are the chances of a positive COPD result?
View original →$AZN With Serena-4 behind, all eyes on Avanzar. Prospective validation of the TROP2 biomarker. Not massive expectations (biomarker added after Tropion data and goes against Keytruda). Best case would be PFS hit in ITT and meaningful effect in biomarker population. OS should be mature enough.
View original →$CNTB crashing already as early Sep guidance missed
View original →